- Epistasis in neurotransmitter receptors linked to posttraumatic stress disorder and major depressive disorder comorbidity in traumatized Chinese
Ling Xu et al, 2024, Frontiers in Psychiatry CrossRef - Investigation of the protective effect of resveratrol in an MK-801-induced mouse model of schizophrenia
Murat Sırrı Akosman et al, 2021, Environmental Science and Pollution Research CrossRef - Bioavailability of Tannins and Other Oligomeric Polyphenols: a Still to Be Studied Phenomenon
Naira Sahakyan et al, 2020, Current Pharmacology Reports CrossRef - Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence
Katarzyna Socała et al, 2024, Phytotherapy Research CrossRef - Natural Phytochemicals for the Treatment of Major Depressive Disorder: A Mini-Review of Pre- and Clinical Studies
Gislaine Z. Réus et al, 2023, CNS & Neurological Disorders - Drug Targets CrossRef - Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery
Yu-Qiong He et al, 2024, Frontiers in Pharmacology CrossRef - Resveratrol reduces the progression of titanium particle‑induced osteolysis via the Wnt/β‑catenin signaling pathway in vivo and in vitro
Xi Chen et al, 2021, Experimental and Therapeutic Medicine CrossRef - Folate supplementation as a beneficial add‐on treatment in relieving depressive symptoms: A meta‐analysis of meta‐analyses
Shan Gao et al, 2024, Food Science & Nutrition CrossRef - Polyphenols in edible herbal medicine: targeting gut-brain interactions in depression-associated neuroinflammation
Wenzhi Hao et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef - Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
Maha Nasr et al, 2023, Metabolic Brain Disease CrossRef